• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease.可溶性环氧化物水解酶是人类疾病大鼠模型中心力衰竭的一个易感因素。
Nat Genet. 2008 May;40(5):529-37. doi: 10.1038/ng.129.
2
Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat.易卒中自发性高血压大鼠中可溶性环氧化物水解酶基因表达和功能的改变与血管疾病风险
Hypertension. 2008 Feb;51(2):567-73. doi: 10.1161/HYPERTENSIONAHA.107.102160. Epub 2007 Dec 17.
3
Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.可溶性环氧化物水解酶缺失通过下调心肌成纤维细胞衍生的成纤维细胞生长因子-2 减轻心肌肥厚。
Crit Care Med. 2014 May;42(5):e345-54. doi: 10.1097/CCM.0000000000000226.
4
Overexpression of soluble epoxide hydrolase reduces post-ischemic recovery of cardiac contractile function.可溶性环氧化物水解酶过表达可减少缺血后心脏收缩功能的恢复。
Biochem Pharmacol. 2024 Oct;228:116237. doi: 10.1016/j.bcp.2024.116237. Epub 2024 Apr 26.
5
Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.人类可溶性环氧化物水解酶基因EPHX2中的多态性与缺血性损伤后的神经元存活有关。
J Neurosci. 2007 Apr 25;27(17):4642-9. doi: 10.1523/JNEUROSCI.0056-07.2007.
6
Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.雄性自发性高血压心力衰竭(SHHF)、自发性高血压(SHR)和 Wistar Kyoto(WKY)大鼠慢性多柔比星治疗的心脏毒性差异。
Toxicol Appl Pharmacol. 2013 Nov 15;273(1):47-57. doi: 10.1016/j.taap.2013.08.012. Epub 2013 Aug 28.
7
Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.可溶性环氧化物水解酶基因缺失与药理抑制对心脏纤维化的相反作用。
PLoS One. 2014 Apr 9;9(4):e94092. doi: 10.1371/journal.pone.0094092. eCollection 2014.
8
Soluble epoxide hydrolase: gene structure, expression and deletion.可溶性环氧化物水解酶:基因结构、表达与缺失。
Gene. 2013 Sep 10;526(2):61-74. doi: 10.1016/j.gene.2013.05.008. Epub 2013 May 20.
9
Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.可溶性环氧化物水解酶(EPHX2)的基因变异与冠心病风险:社区动脉粥样硬化风险(ARIC)研究
Hum Mol Genet. 2006 May 15;15(10):1640-9. doi: 10.1093/hmg/ddl085. Epub 2006 Apr 4.
10
A hypothesis-driven study to comprehensively investigate the association between genetic polymorphisms in EPHX2 gene and cardiovascular diseases: Findings from the UK Biobank.一项以假设为驱动的研究,全面调查EPHX2基因中的基因多态性与心血管疾病之间的关联:来自英国生物银行的研究结果。
Gene. 2022 May 15;822:146340. doi: 10.1016/j.gene.2022.146340. Epub 2022 Feb 18.

引用本文的文献

1
A Comprehensive Analysis of Epoxide Hydrolase 2 (EPHX2) in Pan-Cancer.泛癌中环氧水解酶2(EPHX2)的综合分析
Cancer Rep (Hoboken). 2025 Mar;8(3):e70188. doi: 10.1002/cnr2.70188.
2
The role of CYP-sEH derived lipid mediators in regulating mitochondrial biology and cellular senescence: implications for the aging heart.细胞色素P450可溶性环氧化物水解酶衍生的脂质介质在调节线粒体生物学和细胞衰老中的作用:对衰老心脏的影响
Front Pharmacol. 2024 Dec 5;15:1486717. doi: 10.3389/fphar.2024.1486717. eCollection 2024.
3
The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids.可溶性环氧化物水解酶通过环氧二十碳三烯酸参与心血管疾病的发展。
Front Pharmacol. 2024 Apr 2;15:1358256. doi: 10.3389/fphar.2024.1358256. eCollection 2024.
4
Transcriptome data analysis of primary cardiomyopathies reveals perturbations in arachidonic acid metabolism.原发性心肌病的转录组数据分析揭示了花生四烯酸代谢的紊乱。
Front Cardiovasc Med. 2023 May 23;10:1110119. doi: 10.3389/fcvm.2023.1110119. eCollection 2023.
5
Increased Soluble Epoxide Hydrolase Activity Positively Correlates with Mortality in Heart Failure Patients with Preserved Ejection Fraction: Evidence from Metabolomics.可溶性环氧化物水解酶活性增加与射血分数保留的心力衰竭患者死亡率呈正相关:代谢组学证据
Phenomics. 2022 Oct 27;3(1):34-49. doi: 10.1007/s43657-022-00069-8. eCollection 2023 Feb.
6
The mechanism of Renshen-Fuzi herb pair for treating heart failure-Integrating a cardiovascular pharmacological assessment with serum metabolomics.人参-附子药对治疗心力衰竭的机制——心血管药理学评估与血清代谢组学相结合
Front Pharmacol. 2022 Dec 5;13:995796. doi: 10.3389/fphar.2022.995796. eCollection 2022.
7
Cardiac Disease Alters Myocardial Tissue Levels of Epoxyeicosatrienoic Acids and Key Proteins Involved in Their Biosynthesis and Degradation.心脏疾病改变心肌组织中环氧化物水解酶三烯酸和参与其生物合成和降解的关键蛋白的水平。
Int J Mol Sci. 2022 Oct 17;23(20):12433. doi: 10.3390/ijms232012433.
8
Redox Regulation of Soluble Epoxide Hydrolase-Implications for Cardiovascular Health and Disease.氧化还原调节可溶性环氧化物水解酶——对心血管健康和疾病的影响。
Cells. 2022 Jun 15;11(12):1932. doi: 10.3390/cells11121932.
9
Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury.口服活性环氧二十碳三烯酸类似物在高血压和肾损伤中的作用。
Adv Pharmacol. 2022;94:27-55. doi: 10.1016/bs.apha.2022.02.004. Epub 2022 Mar 30.
10
Epoxylipids and soluble epoxide hydrolase in heart diseases.脂环氧化物和可溶性环氧化物水解酶与心脏疾病。
Biochem Pharmacol. 2022 Jan;195:114866. doi: 10.1016/j.bcp.2021.114866. Epub 2021 Dec 2.

本文引用的文献

1
Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.血管紧张素II在体外和体内均可上调血管内皮细胞中的可溶性环氧化物水解酶。
Proc Natl Acad Sci U S A. 2007 May 22;104(21):9018-23. doi: 10.1073/pnas.0703229104. Epub 2007 May 10.
2
Regulation of the rat CYP4A2 gene promoter by c-Jun and octamer binding protein-1.c-Jun和八聚体结合蛋白-1对大鼠CYP4A2基因启动子的调控
Int J Biochem Cell Biol. 2007;39(6):1235-47. doi: 10.1016/j.biocel.2007.03.019. Epub 2007 Apr 1.
3
Beta-catenin downregulation is required for adaptive cardiac remodeling.β-连环蛋白下调是适应性心脏重塑所必需的。
Circ Res. 2007 May 11;100(9):1353-62. doi: 10.1161/01.RES.0000266605.63681.5a. Epub 2007 Apr 5.
4
Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice.Ephx2基因敲除小鼠体内血压稳态调节的代偿机制。
J Biol Chem. 2007 Feb 2;282(5):2891-8. doi: 10.1074/jbc.M608057200. Epub 2006 Nov 29.
5
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors.可溶性环氧化物水解酶抑制剂对心脏肥大的预防和逆转作用
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18733-8. doi: 10.1073/pnas.0609158103. Epub 2006 Nov 27.
6
Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.可溶性环氧化物水解酶抑制剂的心血管治疗方面
Cardiovasc Drug Rev. 2006 Summer;24(2):169-88. doi: 10.1111/j.1527-3466.2006.00169.x.
7
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.可溶性环氧化物水解酶在心脏收缩功能缺血后恢复中的作用。
Circ Res. 2006 Aug 18;99(4):442-50. doi: 10.1161/01.RES.0000237390.92932.37. Epub 2006 Jul 20.
8
Trends in prevalence and outcome of heart failure with preserved ejection fraction.射血分数保留的心力衰竭的患病率及预后趋势
N Engl J Med. 2006 Jul 20;355(3):251-9. doi: 10.1056/NEJMoa052256.
9
Association of parental heart failure with risk of heart failure in offspring.父母心力衰竭与子代心力衰竭风险的关联。
N Engl J Med. 2006 Jul 13;355(2):138-47. doi: 10.1056/NEJMoa052948.
10
Genetic susceptibility to coronary artery disease: from promise to progress.冠状动脉疾病的遗传易感性:从希望到进展。
Nat Rev Genet. 2006 Mar;7(3):163-73. doi: 10.1038/nrg1805.

可溶性环氧化物水解酶是人类疾病大鼠模型中心力衰竭的一个易感因素。

Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease.

作者信息

Monti Jan, Fischer Judith, Paskas Svetlana, Heinig Matthias, Schulz Herbert, Gösele Claudia, Heuser Arnd, Fischer Robert, Schmidt Cosima, Schirdewan Alexander, Gross Volkmar, Hummel Oliver, Maatz Henrike, Patone Giannino, Saar Kathrin, Vingron Martin, Weldon Steven M, Lindpaintner Klaus, Hammock Bruce D, Rohde Klaus, Dietz Rainer, Cook Stuart A, Schunck Wolf-Hagen, Luft Friedrich C, Hubner Norbert

机构信息

Max-Delbrück Center for Molecular Medicine, Robert-Rössle-Strasse 10, 13125 Berlin, Germany.

出版信息

Nat Genet. 2008 May;40(5):529-37. doi: 10.1038/ng.129.

DOI:10.1038/ng.129
PMID:18443590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7370537/
Abstract

We aimed to identify genetic variants associated with heart failure by using a rat model of the human disease. We performed invasive cardiac hemodynamic measurements in F2 crosses between spontaneously hypertensive heart failure (SHHF) rats and reference strains. We combined linkage analyses with genome-wide expression profiling and identified Ephx2 as a heart failure susceptibility gene in SHHF rats. Specifically, we found that cis variation at Ephx2 segregated with heart failure and with increased transcript expression, protein expression and enzyme activity, leading to a more rapid hydrolysis of cardioprotective epoxyeicosatrienoic acids. To confirm our results, we tested the role of Ephx2 in heart failure using knockout mice. Ephx2 gene ablation protected from pressure overload-induced heart failure and cardiac arrhythmias. We further demonstrated differential regulation of EPHX2 in human heart failure, suggesting a cross-species role for Ephx2 in this complex disease.

摘要

我们旨在通过使用人类疾病的大鼠模型来鉴定与心力衰竭相关的基因变异。我们在自发性高血压心力衰竭(SHHF)大鼠与参考品系之间的F2杂交后代中进行了有创心脏血流动力学测量。我们将连锁分析与全基因组表达谱分析相结合,并确定Ephx2是SHHF大鼠中的一个心力衰竭易感基因。具体而言,我们发现Ephx2的顺式变异与心力衰竭以及转录本表达增加、蛋白质表达增加和酶活性增加相关,导致具有心脏保护作用的环氧二十碳三烯酸的水解加快。为了证实我们的结果,我们使用基因敲除小鼠测试了Ephx2在心力衰竭中的作用。Ephx2基因缺失可预防压力超负荷诱导的心力衰竭和心律失常。我们进一步证明了EPHX2在人类心力衰竭中的差异调节,表明Ephx2在这种复杂疾病中具有跨物种作用。